FindTrial
Sign In

To study the effect of Amrabeejadi lepa in the management of Dandruff.

Randomized control clinical trial to study the efficacy of Amrabeejadi lepa in the management of Darunaka.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046639
Enrollment
64
Registered
2022-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L218- Other seborrheic dermatitis

Interventions

None listed

Sponsors

Bharatiya Sanskriti Darshan Trust Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1] Patients between age group 16 to 50 years of either gender. 2] Patients having symptoms of Darunaka like Keshbhumi twaksphutan (cracking skin), Keshbhumi Kandu (itching), Keshbhumi Rukshata (dryness or roughness of scalp), Keshachyuti (hair fall). 3] Patients having minimum 2-3 or above-mentioned symptoms.

Exclusion criteria

Exclusion criteria: 1] Patient with severe scalp infection like psoriasis, eczema etc. 2] Patient with history of hypersensitivity. 3] Patient with preexisting severe systemic diseases

Design outcomes

Primary

MeasureTime frame
To observe and document the effect of Amrabeejadi Lepa in the management of Darunaka.Timepoint: Assessment on 0th, 10th, 21st, 31st day—

Secondary

MeasureTime frame
To Observe and document the comparative effect of Amrabeejadi Lepa and Triphaladi Taila in the management of DarunakaTimepoint: Assessment on 0th, 10th, 21st,31st day—

Countries

India

Contacts

Public ContactDr Anjali Aniruddha Deshpande

Bharatiya Sanskriti Darshan Trust Ayurved Mahavidyalaya

anjalidesh1610@gmail.com9730069747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026